Obesity is a problem with great importance and certain actuality in the field of paediatric pathology because of its increased incidence in children and its complications. Fat mass and obesity associated (FTO) genes are related with weight gain and obesity during childhood, being correlated with body mass index (BMI) and leptin levels.
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The aim of our study was to establish the role of the polymorphisms of rs9939609 and rs17817449 FTO genes in determining obesity in a child population from Romania. Methods We assessed 225 hospitalised children in a tertiary emergency paediatric hospital divided into: control group -110 patients with normal nutritional status and obese group -105 patients. The two groups underwent the evaluation of FTO rs17817449 and rs 9939609 SNP, and the measurement of anthropometric parameters [ Background and aims Reactive hyperemia-peripheral artery tonometry (RH-PAT) is a non-invasive method for endothelial function assessment. The goal of this study is to investigate endothelial function as assessed with the RH-PAT in control adolescents and adolescents with type 1 diabetes (T1D) or overweight. Methods RH-PAT score and baseline pulse amplitude was measured after an overnight fast in 25 control subjects (age 12-20 years), 34 adolescents with T1D and 27 adolescents with overweight or obesity.
Results RH-PAT score was lower in adolescents with T1D com- Conclusions Endothelial dysfunction, quantified by lower RH-PAT score or higher baseline pulse amplitude, was observed in both adolescents with T1D and with overweight. Early detection of vascular changes in these high-risk patient groups may allow targeted interventions to reduce cardiovascular disease in adulthood. Background and aims Concurrent with the rise of the incidence in obesity, metabolic syndrome (MS) is increasingly prevalent in obese adolescents. Adiponectin is a major regulator of glucose and lipid homeostasis. Decreased adiponectin levels may be linked to MS. We aimed to test the hypothesis that adiponectin would influence the risk of MS in obese adolescents independent of its insulin sensitizer properties. Methods This study was a cross-sectional study of the risk factors for MS in obese adolescents. A total of 593 obese subjects aged 10-18 years were recruited. International Diabetes Federation (IDF) consensus was used to define MS. We measured anthropometric, serum biochemical variables, serum adiponectin levels, and biomarkers for insulin resistance. We evaluated the independent influence of the adiponectin level on MS after controlling for the effect of insulin resistance measured by HOMA-IR.
O-052

25-HYDROXY VIT D, ADIPONECTIN LEVELS AND CARDIOMETABOLIC RISK FACTORS IN
Results 83 (14%) had MS. Obese adolescents with MS had significantly higher HOMA-IR and lower adiponectin levels than obese adolescents without MS. The adiponectin levels decreased with increasing number of metabolic syndrome components present in obese adolescents (p < 0.001). In multivariate logistic regression analysis, MS was significantly associated with age, body mass index, HOMA-IR, and adiponectin. For every 1µg/ mL decrease in serum adiponectin level, there was an increased risk of having MS with an odds ratio of 1.229 (95% confidence interval, 1.112 to 1.358, p < 0.001).
Conclusions Decreased serum adiponectin level is associated with an increased risk for MS independent of the effects of age, BMI, and insulin resistance in our population of obese Taiwanese adolescents. Backgrounds and aims The aim of our study was to determine the usefulness and feasibility of transient elastography (FibroScan) assessing liver stiffness and hepatic fat deposition in obese children.
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Methods Obese children (Obese group; BMI-SDS above 90th percentile) and non-obese children without liver disease (Control group) were examined for liver stiffness measurement (LSM) with simultaneous controlled attenuation parameter (CAP) using Fibroscan. LSM and CAP were compared with clinical, biochemical, ultrasound and histological data.
Results Obese group (n = 40, 12.4 y ± 3.6 y) and the control group (n = 78, 10.6 y ± 4.2 y) were evaluated for the study. Liver biopsy was performed in 5 patients. The CAP was significantly correlated with ultrasound fatty liver score (r = 0.806, p = 0.028) and histological steatosis grade (r = 0.819, p = 0.016). The LSM was significantly correlated with histological fibrosis grade (r = 0.848, p = 0.005). The CAP of the obese group (293.27 ± 55.72 dB/m) showed significantly higher value than control group (179.45 ± 44.75dB/m) (p < 0.0001). The LSM showed significantly higher value in the obese group compared to the control group (5.7 ± 2.3 kPa vs 3.9 ± 0.9 kPa, p < 0.0001). In the control group, no biochemical parameters were correlated with LSM or CAP. In the obese group, the LSM correlated to the aspartate aminotransferase (r = 0.694, p < 0.0001) and the alanine aminotransferase (r = 0.6748, p < 0.0001), whereas the CAP correlated to no parameters. Conclusions FibroScan is a non-invasive tool to assess the liver stiffness and hepatic fat deposition simultaneously thus useful as a screening tool for nonalcoholic fatty liver disease especially in obese children. ]), who underwent MRI within 21 days of birth and neurodevelopmental assessment at ≥12 months. Infants with a DQ >2SDs below the mean were considered to Abstract O-055 Figure 1 Graphs showing receiver operating characteristic curves to estimate outcome with FA in WM (A), MD in thalami (B) and cortex (C)
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